Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel NMD-escaping STAG2 variant associated with syndromic neurodevelopmental delay, growth failure, and distinctive dysmorphism: expanding the phenotype in male patients and literature review.

Gene·2026
Same author

Sex-determining Region of Y-gene Translocation and 46,XX Testicular Disorders of Sex Development: Cytogenetic and Molecular Insights into Male Infertility.

Journal of human reproductive sciences·2026
Same author

A novel case of autosomal-dominant cutis laxa caused by a de novo likely pathogenic variant in ALDH18A1: case report and literature review.

Journal of human genetics·2025
Same author

Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial.

The Journal of antimicrobial chemotherapy·2025
Same author

Structural basis of phosphate export by human XPR1.

Cell research·2025
Same author

Investigation of the Structure and Functional Activity of the YqeK Protein in <i>Streptococcus pyogenes</i> with High Efficiency in Hydrolyzing Ap4A.

Microorganisms·2025

Related Experiment Video

Updated: Jul 15, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

Magnetic resonance fingerprinting in multiple sclerosis.

Daniel Ontaneda1, Vikas Gulani2, Anagha Deshmane3

  • 1Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States.

Multiple Sclerosis and Related Disorders
|October 2, 2023
PubMed
Summary

Magnetic Resonance Fingerprinting (MRF) reveals increased T1 and T2 relaxation times in multiple sclerosis (MS) brain tissue, correlating with disease severity. This quantitative imaging technique shows promise for assessing MS-related tissue damage.

Keywords:
Magnetic resonance fingerprintingMultiple sclerosisQuantitative MRIRelaxation

More Related Videos

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.6K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.5K

Related Experiment Videos

Last Updated: Jul 15, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.6K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.5K

Area of Science:

  • Neuroimaging
  • Quantitative MRI
  • Biophysics

Background:

  • Multiple Sclerosis (MS) is a demyelinating disease affecting white and gray matter.
  • Assessing tissue properties in MS is crucial for understanding disease progression and treatment efficacy.
  • Conventional MRI methods have limitations in quantifying subtle tissue changes.

Purpose of the Study:

  • To investigate brain tissue properties using Magnetic Resonance Fingerprinting (MRF) in patients with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS).
  • To compare MRF-derived T1 and T2 relaxation times between MS patients and healthy controls (HC).
  • To explore the correlation between MRF parameters and clinical disability measures in MS.

Main Methods:

  • Cross-sectional study involving 21 RRMS, 16 SPMS, and 9 HC.
  • Acquisition of a fast imaging sequence with steady-state free precession (FISP)-based MRF at 3T.
  • Measurement of T1 and T2 relaxation times in various brain regions, including normal-appearing white matter, gray matter, and lesions.
  • Statistical analysis using ANCOVA adjusted for age and sex, and Spearman rank correlations.

Main Results:

  • A stepwise increase in T1 and T2 relaxation times was observed from HC to RRMS to SPMS.
  • Significant differences in T1 and T2 values were found between MS patients and HC in the frontal normal-appearing white matter, corpus callosum, and thalamus.
  • T1 relaxation in the frontal normal-appearing white matter showed significant correlations with Expanded Disability Status Scale (EDSS), timed 25-foot walk, 9-hole peg test, and paced auditory serial addition test.

Conclusions:

  • MRF provides a clinically feasible quantitative method for characterizing tissue damage in MS.
  • MRF-derived relaxation times can differentiate between MS subtypes and healthy controls.
  • MRF parameters correlate with clinical disability, suggesting its potential as a biomarker for MS progression.